Use of dehydrated human amnion chorion membrane allograft on infected ruptured arteriovenous fistula: revision and closure. (1st October 2019)

• Record Type: Journal Article
• Authors: Al-Khateeb, Mutaz; Al-Muzakki, Zaki; Ftyan, Mohammed; Itani, Hussam; Istwan, Niki; Tettelbach, William
• Is Part Of: Journal of wound care. Volume 28(2019)Supplement 10
• Page Start: S10
• Page End: S12
• Publication Date: 2019-10-01
• Subjects: amniotic membrane allograft -- dehydrated human amnion chorion membrane -- arteriovenous fistula -- wound care; Wounds and injuries -- Treatment -- Periodicals; Wound healing -- Periodicals; 617.1
• DOI: 10.12968/jowc.2019.28.Sup10.S10
• Languages: English
• ISSNs: 0969-0700

Abstract

Abstract : Objective: Over two million individuals worldwide, with end-stage renal disease (ESRD), depend on dialysis therapy or a kidney transplant for survival. Every haemodialysis patient requires vascular access. The arteriovenous fistula (AVF) is preferred for long-term hemodialysis vascular access due to long-term primary patency rates. Given the limited options for haemodialysis access and placement, preservation of existing AVF sites is always a clinical priority. This case report describes a novel approach to wound closure with the application of dehydrated amnion chorion human membrane (dHACM) at an AVF surgical site known to be complicated with issues of scarring and tissue breakdown. The patient was treated successfully with the imperative preservation of his AVF given that he had few other vascular access options.